You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neoantigen

Showing 1 - 25 of 213
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Neoantigen peptide vaccine
  • Neoantigen-based DC immune preparation
  • Nanchang, Jiangxi, China
    First Affiliated Hospital of Nanchang University
Mar 1, 2023

Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

Not yet recruiting
  • Adrenal Cortical Carcinoma
  • +3 more
  • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023

Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Optimized neoantigen synthetic long peptide

Recruiting
  • Pancreas Cancer
  • +2 more
  • Optimized neoantigen synthetic long peptide vaccine
  • Poly-ICLC
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 23, 2023

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01 in combination with standard adjuvant therapy
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)

Enrolling by invitation
  • Cancer
  • Solid Tumor
  • Personalized Synthetic Long Peptide Vaccine
  • San Francisco, California
    Quest Clinical Research
Feb 20, 2023

Unmethylated Glioblastoma Trial in Saint Louis (Personalized Neoantigen DNA vaccine, Retifanlimab, TDS-IM v 2.0 electroporation

Not yet recruiting
  • Unmethylated Glioblastoma
  • Personalized Neoantigen DNA vaccine
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 14, 2023

Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

Recruiting
  • Digestive System Neoplasms
  • iNeo-Vac-R01
  • Hangzhou, Zhejiang, China
    Department of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023

Tumors Trial in Tijuana (Neoantigen Peptides)

Recruiting
  • Neoplasms
  • Neoantigen Peptides
  • Tijuana, Baja California, Mexico
    Instituto de Medicina Regenerativa
Jul 22, 2022

Refractory Tumor, Solid Tumor Trial in Kaohsiung, Tainan (Dendritic Cell Vaccine, Lenvatinib, Nivolumab)

Not yet recruiting
  • Refractory Tumor
  • Solid Tumor
  • Dendritic Cell Vaccine
  • +2 more
  • Kaohsiung, Taiwan
  • +2 more
Mar 2, 2023

NSCLC, EGFR Gene Mutation Trial in Nanjing (neo-antigen vaccine)

Recruiting
  • NSCLC
  • EGFR Gene Mutation
  • neo-antigen vaccine
  • Nanjing, China
    The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital,
Oct 19, 2023

Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA

Recruiting
  • Lynch Syndrome
  • Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
  • +2 more
  • Duarte, California
  • +3 more
Nov 22, 2022

Diffuse Intrinsic Pontine Glioma Trial in Beijing (Histone H3.3-K27M Neoantigen Vaccine Therapy)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Histone H3.3-K27M Neoantigen Vaccine Therapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Jul 18, 2022

Peripheral Blood Neoantigen Specific T Cells Predict Efficacy of

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shanghai, Shanghai, China
      Cancer hospital Fudan University
    Nov 30, 2022

    Resectable Esophageal Cancer Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

    Recruiting
    • Resectable Esophageal Cancer
    • iNeo-Vac-P01
    • GM-CSF
    • Hangzhou, Zhejiang, China
      The Second Affiliated Hospital of Zhejiang University
    Mar 23, 2022

    Pancreatic Tumor Trial in Shanghai (Personalized neoantigen vaccine)

    Recruiting
    • Pancreatic Tumor
    • Personalized neoantigen vaccine
    • Shanghai, Shanghai, China
      Changhai Hospital
    Mar 8, 2022

    Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Baltimore (Neoantigen Vaccine with Poly-ICLC adjuvant,

    Not yet recruiting
    • Pancreatic Cancer Metastatic
    • Colorectal Cancer Metastatic
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center
    Aug 5, 2022

    Solid Tumor Trial in Beijing (Personalized neoantigen tumor vaccine)

    Not yet recruiting
    • Solid Tumor
    • Personalized neoantigen tumor vaccine
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 28, 2022

    Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer Trial in Singapore (Neoantigen Dendritic Cell Vaccine,

    Recruiting
    • Hepatocellular Carcinoma
    • +4 more
    • Singapore, Singapore
      National Cancer Center Singapore
    Aug 17, 2022

    Triple Negative Breast Cancer, Triple Negative Breast Tumors, TNBC - Triple-Negative Breast Cancer Trial in Saint Louis (drug,

    Active, not recruiting
    • Triple Negative Breast Cancer
    • +3 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Mar 14, 2022

    Advanced Renal Cell Carcinoma Trial in Heilbronn (IVAC)

    Recruiting
    • Advanced Renal Cell Carcinoma
    • IVAC
    • Heilbronn, Germany
      SLK Kliniken Heilbronn, Klinik für Innere Medizin III: Hämatolog
    Nov 30, 2022

    Advanced Malignant Solid Tumors Trial (Neoantigen mRNA Personalised Cancer vaccine)

    Not yet recruiting
    • Advanced Malignant Solid Tumors
    • Neoantigen mRNA Personalised Cancer vaccine
    • (no location specified)
    Jul 16, 2023

    Metastatic Hormone-Sensitive Prostate Cancer Trial in Saint Louis (biological, drug, device, procedure)

    Completed
    • Metastatic Hormone-Sensitive Prostate Cancer
    • PROSTVAC-V
    • +9 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Aug 3, 2022

    Solid Tumor Trial in Wuhan (Neo-T, Cyclophosphamide, Fludarabine)

    Recruiting
    • Solid Tumor
    • Neo-T
    • +3 more
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Mar 23, 2023

    Solid Tumor Trial in Shanghai (Neo-T, Cyclophosphamide, Fludarabine)

    Recruiting
    • Solid Tumor
    • Neo-T
    • +3 more
    • Shanghai, China
    • +1 more
    Mar 23, 2023